IGM Biosciences Inc (NAS:IGMS)
$ 9.22 -0.07 (-0.75%) Market Cap: 544.20 Mil Enterprise Value: 295.49 Mil PE Ratio: 0 PB Ratio: 3.40 GF Score: 36/100

IGM Biosciences Inc at Jefferies Healthcare Conference Transcript

Jun 08, 2023 / 05:30PM GMT
Release Date Price: $11.09 (+4.52%)
Roger Song
Jefferies & Company, Inc. - Analyst

All right. Okay, everyone. Day two, 2023 Jefferies Healthcare Conference. My name is Roger Song, one of the senior analysts covering biotech semi-cap. Our next presenting company is IGM Biosciences. With me is CEO, Fred. Welcome.

Fred Schwarzer
IGM Biosciences, Inc. - President, CEO, & Director

Well, thanks very much. I'm going to impose a little bit on you and show a few slides that are just a little bit of a short recap of what we presented that at the time of ASCO last Friday night. And so, I thought maybe it would be worthwhile to just do a little bit of a quick overview.

Roger Song
Jefferies & Company, Inc. - Analyst

Excellent. Thank you.

Fred Schwarzer
IGM Biosciences, Inc. - President, CEO, & Director

I'll try to be quick. Okay. So I am going to make some forward-looking statements, and I'm afraid I have to refer you to our risk factors and all of our SEC filings.

So DR5 has been a target

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot